OncoCare Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 6

OncoCare General Information

Description

Developer of tumor molecular diagnostic products. The company's self-developed MeMore methylation hypersensitivity joint detection technology can be combined with artificial intelligence to evaluate the risk level of lung cancer, colorectal cancer and liver cancer, enabling clients to improve diagnosis efficiency.

Contact Information

Website
www.oncocares.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 9, Jiangsu Medical Device Industrial Park
  • No. 8 Jinfeng Road, Science and Technology City, Suzhou High-tech Zone
  • Suzhou, Jiangsu
  • China
+86 400
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Building 9, Jiangsu Medical Device Industrial Park
  • No. 8 Jinfeng Road, Science and Technology City, Suzhou High-tech Zone
  • Suzhou, Jiangsu
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoCare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A1) 08-Sep-2021 Completed Generating Revenue
1. Later Stage VC (Series A) 01-Apr-2021 Completed Generating Revenue
To view OncoCare’s complete valuation and funding history, request access »

OncoCare Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

OncoCare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210104315-A1 Engagement for individuals with disabilities Inactive 08-Oct-2019

OncoCare Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Addor Capital Growth/Expansion Minority
Suzhou Oriza Holdings Corporation Asset Manager Minority
Guoqian Venture Capital Venture Capital Minority
Honest Capital Venture Capital Minority
Huatai Zijin Investment Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

OncoCare FAQs

  • When was OncoCare founded?

    OncoCare was founded in 2015.

  • Where is OncoCare headquartered?

    OncoCare is headquartered in Suzhou, China.

  • What industry is OncoCare in?

    OncoCare’s primary industry is Diagnostic Equipment.

  • Is OncoCare a private or public company?

    OncoCare is a Private company.

  • What is OncoCare’s current revenue?

    The current revenue for OncoCare is .

  • Who are OncoCare’s investors?

    Addor Capital, Suzhou Oriza Holdings Corporation, Guoqian Venture Capital, Honest Capital, and Huatai Zijin Investment are 5 of 6 investors who have invested in OncoCare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process